Sabiporide
Alternative Names: BIIB 722CLLatest Information Update: 14 Nov 2014
At a glance
- Originator Boehringer Ingelheim
- Class Anti-ischaemics; Guanidines; Small molecules
- Mechanism of Action Sodium-hydrogen antiporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Ischaemic heart disorders